The University of Southampton
University of Southampton Institutional Repository

RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1

RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1
RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1
The classical paradigm of mutation screening seeks to relate alterations in DNA sequence to their effect at the protein level. However, the majority of missense mutations are problematic as their pathological significance is often unclear. In order to test the hypothesis that many missense mutations primarily cause defects at the RNA rather than the protein level, we have performed retrospective RNA analysis of 12 individuals carrying missense mutations in the cancer predisposition genes APC, BRCA1, BRCA2, MLH1, and MSH2. RNA was extracted from peripheral blood samples and RT-PCR performed in order to assess the splicing and expression of the mutant allele in each case. Four of the 12 missense mutations analysed were associated with RNA defects. We detected two cases of exon skipping and one case of partial intron inclusion with activation of a cryptic intronic splice site in MLH1. A fourth case was associated with monoallelic expression of BRCA1. In addition, allele-specific analysis of common coding polymorphisms identified a further case of monoallelic BRCA1 expression in one of two individuals who had previously screened as mutation-negative. Although we were unable to identify the underlying cause of this loss of expression, it strongly suggests the presence of a pathogenic defect in BRCA1 in this case, highlighting the use of allelic expression studies as a method of mutation scanning. Finally, we used our dataset to test the ability of several in silico sequence analysis tools to identify splicing defects. Our results suggest that a significant number of missense mutations in cancer predisposition genes are associated with defects of RNA splicing, and that the use of gene- and splice site prediction software can aid in identifying such mutations.
splicing, exon splice enhancer, ese, brca1, brca2, mlh1, msh2
1059-7794
272-272
Sharp, Andrew
ee3d8496-53a4-40de-ba16-add24d70b515
Pichert, Gabriella
2f767134-7791-42b4-9b80-50e978ab2495
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23
Sharp, Andrew
ee3d8496-53a4-40de-ba16-add24d70b515
Pichert, Gabriella
2f767134-7791-42b4-9b80-50e978ab2495
Lucassen, Anneke
2eb85efc-c6e8-4c3f-b963-0290f6c038a5
Eccles, Diana
5b59bc73-11c9-4cf0-a9d5-7a8e523eee23

Sharp, Andrew, Pichert, Gabriella, Lucassen, Anneke and Eccles, Diana (2004) RNA analysis reveals splicing mutations and loss of expression defects in MLH1 and BRCA1. Human Mutation, 24 (3), 272-272. (doi:10.1002/humu.9267).

Record type: Article

Abstract

The classical paradigm of mutation screening seeks to relate alterations in DNA sequence to their effect at the protein level. However, the majority of missense mutations are problematic as their pathological significance is often unclear. In order to test the hypothesis that many missense mutations primarily cause defects at the RNA rather than the protein level, we have performed retrospective RNA analysis of 12 individuals carrying missense mutations in the cancer predisposition genes APC, BRCA1, BRCA2, MLH1, and MSH2. RNA was extracted from peripheral blood samples and RT-PCR performed in order to assess the splicing and expression of the mutant allele in each case. Four of the 12 missense mutations analysed were associated with RNA defects. We detected two cases of exon skipping and one case of partial intron inclusion with activation of a cryptic intronic splice site in MLH1. A fourth case was associated with monoallelic expression of BRCA1. In addition, allele-specific analysis of common coding polymorphisms identified a further case of monoallelic BRCA1 expression in one of two individuals who had previously screened as mutation-negative. Although we were unable to identify the underlying cause of this loss of expression, it strongly suggests the presence of a pathogenic defect in BRCA1 in this case, highlighting the use of allelic expression studies as a method of mutation scanning. Finally, we used our dataset to test the ability of several in silico sequence analysis tools to identify splicing defects. Our results suggest that a significant number of missense mutations in cancer predisposition genes are associated with defects of RNA splicing, and that the use of gene- and splice site prediction software can aid in identifying such mutations.

This record has no associated files available for download.

More information

Published date: September 2004
Additional Information: Mutation in brief
Keywords: splicing, exon splice enhancer, ese, brca1, brca2, mlh1, msh2

Identifiers

Local EPrints ID: 26602
URI: http://eprints.soton.ac.uk/id/eprint/26602
ISSN: 1059-7794
PURE UUID: 93a72938-0f15-468e-8f63-8f2f395dc01b
ORCID for Anneke Lucassen: ORCID iD orcid.org/0000-0003-3324-4338
ORCID for Diana Eccles: ORCID iD orcid.org/0000-0002-9935-3169

Catalogue record

Date deposited: 20 Apr 2006
Last modified: 16 Mar 2024 03:23

Export record

Altmetrics

Contributors

Author: Andrew Sharp
Author: Gabriella Pichert
Author: Anneke Lucassen ORCID iD
Author: Diana Eccles ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×